Modalis Therapeutics Corporation (TYO:4883)

Japan flag Japan · Delayed Price · Currency is JPY
78.00
0.00 (0.00%)
Apr 24, 2025, 3:30 PM JST
1.30%
Market Cap 5.74B
Revenue (ttm) n/a
Net Income (ttm) -1.32B
Shares Out 73.55M
EPS (ttm) -28.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 273,600
Average Volume 1,868,565
Open 79.00
Previous Close 78.00
Day's Range 78.00 - 80.00
52-Week Range 62.00 - 203.00
Beta 0.16
RSI 43.43
Earnings Date May 7, 2025

About Modalis Therapeutics

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. Th... [Read more]

Sector Healthcare
Founded 2016
Employees 14
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4883
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.